|
Volumn 29, Issue 9, 2002, Pages 1920-1930
|
Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects
a a a a a a a a |
Author keywords
Cartilage; Gene therapy; Muscle derived cells; Retroviral vector; Tissue engineering
|
Indexed keywords
BETA GALACTOSIDASE;
COLLAGEN TYPE 1;
COLLAGEN TYPE 2;
ANIMAL CELL;
ANIMAL TISSUE;
ARTICLE;
ARTICULAR CARTILAGE;
CARTILAGE CELL;
CELL COUNT;
CELL PROLIFERATION;
CELL TRANSPLANTATION;
CHONDROPATHY;
CONTROLLED STUDY;
GENE EXPRESSION;
GENE THERAPY;
MUSCLE CELL;
NONHUMAN;
PRIORITY JOURNAL;
RABBIT;
RETROVIRUS;
TISSUE REPAIR;
TRANSGENE;
VIRAL GENE DELIVERY SYSTEM;
ANALYSIS OF VARIANCE;
ANIMALS;
CARTILAGE DISEASES;
CARTILAGE, ARTICULAR;
CELL TRANSPLANTATION;
CHONDROCYTES;
CULTURE TECHNIQUES;
DISEASE MODELS, ANIMAL;
FEMALE;
GELS;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
IMMUNOHISTOCHEMISTRY;
MALE;
MUSCLE, SKELETAL;
PROBABILITY;
RABBITS;
REFERENCE VALUES;
SENSITIVITY AND SPECIFICITY;
STATISTICS, NONPARAMETRIC;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 0036731957
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (134)
|
References (37)
|